Nanoparticle-programmed self-destructive neural stem cells for glioblastoma targeting and therapy

Small

Volumn 9, Issue 24, 2013, Pages 4123-4129

  Cheng, Yu ^a   Morshed, Ramin ^a   Cheng, Shih Hsun ^a   Tobias, Alex ^a   Auffinger, Brenda ^a   Wainwright, Derek A ^a   Zhang, Lingjiao ^a   Yunis, Catherine ^a   Han, Yu ^a   Chen, Chin Tu ^a   Lo, Leu Wei ^b   Aboody, Karen S ^c   Ahmed, Atique U ^a   Lesniak, Maciej S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

doxorubicin; drug delivery; glioblastoma; glioma; mesoporous silica nanoparticles; neural stem cells; targeted delivery

Indexed keywords

DOXORUBICIN; GLIOBLASTOMAS; GLIOMA; MESOPOROUS SILICA NANOPARTICLES; NEURAL STEM CELL; TARGETED DELIVERY;

CELL DEATH; DRUG DELIVERY; NANOPARTICLES; TUMORS;

STEM CELLS;

DOXORUBICIN; NANOPARTICLE;

ANIMAL; APOPTOSIS; ARTICLE; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL DEATH; CELL MOTION; CHEMISTRY; CLINICAL TRIAL (TOPIC); CYTOLOGY; DRUG DELIVERY SYSTEM; FLUORESCENCE MICROSCOPY; GLIOBLASTOMA; GLIOMA; HUMAN; LYSOSOME; MESOPOROUS SILICA NANOPARTICLES; MOUSE; NANOMEDICINE; NEURAL STEM CELL; PH; TARGETED DELIVERY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; ULTRASTRUCTURE;

DOXORUBICIN; DRUG DELIVERY; GLIOBLASTOMA; GLIOMA; MESOPOROUS SILICA NANOPARTICLES; NEURAL STEM CELLS; TARGETED DELIVERY;

ANIMALS; APOPTOSIS; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL MOVEMENT; CLINICAL TRIALS AS TOPIC; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GLIOBLASTOMA; HUMANS; HYDROGEN-ION CONCENTRATION; LYSOSOMES; MICE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NANOMEDICINE; NANOPARTICLES; NEOPLASM TRANSPLANTATION; NEURAL STEM CELLS;

EID: 84890471760     PISSN: 16136810     EISSN: 16136829     Source Type: Journal    
DOI: 10.1002/smll.201301111     Document Type: Article

References (30)

1. a) S. A. Grossman, X. B. Ye, S. Piantadosi, S. Desideri, L. B. Nabors, M. Rosenfeld, J. Fisher, N. C. Consortium, Clin. Cancer Res. 2010, 16, 2443-2449
2. b) P. Y. Wen, S. Kesari, N. Engl. J. Med. 2008, 359, 492-507.
3. a) M. E. Davis, Z. Chen, D. M. Shin, Nat. Rev. Drug Discov. 2008, 7, 771-782
4. b) L. Zhang, F. X. Gu, J. M. Chan, A. Z. Wang, R. S. Langer, O. C. Farokhzad, Clin. Pharmacol. Ther. 2008, 83, 761-769
5. c) O. C. Farokhzad, R. Langer, ACS Nano 2009, 3, 16-20.
6. J. B. Zhou, K. B. Atsina, B. T. Himes, G. W. Strohbehn, W. M. Saltzman, Cancer J. 2012, 18, 89-99.
7. a) K. S. Aboody, A. Brown, N. G. Rainov, K. A. Bower, S. X. Liu, W. Yang, J. E. Small, U. Herrlinger, V. Ourednik, P. M. Black, X. O. Breakefield, E. Y. Snyder, Proc. Natl. Acad. Sci. USA 2000, 97, 12846-12851
8. b) M. S. Lesniak, Expert Rev. Neurother. 2006, 6, 1-3
9. c) F. J. Muller, E. Y. Snyder, J. F. Loring, Nat. Rev. Neurosci. 2006, 7, 167-167
10. d) A. U. Ahmed, M. S. Lesniak, Expert Rev. Neurother. 2011, 11, 775-777
11. e) A. U. Ahmed, N. G. Alexiades, M. S. Lesniak, Curr. Opin. Mol. Ther. 2010, 12, 546-552.
12. a) A. M. Sonabend, I. V. Ulasov, M. A. Tyler, A. A. Rivera, J. M. Mathis, M. S. Lesniak, Stem Cells 2008, 26, 831-841
13. b) J. Kranzler, M. A. Tyler, A. M. Sonabend, I. V. Ulasov, M. S. Lesniak, Curr. Gene Ther. 2009, 9, 389-395
14. c) M. A. Tyler, I. V. Ulasov, A. M. Sonabend, S. Nandi, Y. Han, S. Marler, J. Roth, M. S. Lesniak, Gene Ther. 2009, 16, 262-278
15. d) A. U. Ahmed, C. E. Rolle, M. A. Tyler, Y. Han, S. Sengupta, D. A. Wainwright, I. V. Balyasnikova, I. V. Ulasov, M. S. Lesniak, Mol. Ther. 2010, 18, 1846-1856
16. e) I. V. Balyasnikova, S. D. Ferguson, S. Sengupta, Y. Han, M. S. Lesniak, PLoS One 2010, 5, e9750.
17. a) L. L. Li, Y. Q. Guan, H. Y. Liu, N. J. Hao, T. L. Liu, X. W. Meng, C. H. Fu, Y. Z. Li, Q. L. Qu, Y. G. Zhang, S. Y. Ji, L. Chen, D. Chen, F. Q. Tang, ACS Nano 2011, 5, 7462-7470
18. b) M. Roger, A. Clavreul, M. C. Venier-Julienne, C. Passirani, C. Montero-Menei, P. Menei, Biomaterials 2011, 32, 2106-2116
19. c) Z. Gao, L. Zhang, J. Hu, Y. Sun, Nanomedicine 2012, DOI:10.1016/j.nano.2012.06.003
20. d) M. Roger, A. Clavreul, N. T. Huynh, C. Passirani, P. Schiller, A. Vessieres, C. Montero-Menei, P. Menei, Int. J. Pharm. 2012, 423, 63-68.
21. C. H. Lee, S. H. Cheng, I. P. Huang, J. S. Souris, C. S. Yang, C. Y. Mou, L. W. Lo, Angew. Chem. Int. Ed. 2010, 49, 8214-8219.
22. C. E. Ashley, E. C. Carnes, G. K. Phillips, D. Padilla, P. N. Durfee, P. A. Brown, T. N. Hanna, J. W. Liu, B. Phillips, M. B. Carter, N. J. Carroll, X. M. Jiang, D. R. Dunphy, C. L. Willman, D. N. Petsev, D. G. Evans, A. N. Parikh, B. Chackerian, W. Wharton, D. S. Peabody, C. J. Brinker, Nat. Mater. 2011, 10, 389-397.
23. K. K. Coti, M. E. Belowich, M. Liong, M. W. Ambrogio, Y. A. Lau, H. A. Khatib, J. I. Zink, N. M. Khashab, J. F. Stoddart, Nanoscale 2009, 1, 16-39.
24. I. I. Slowing, J. L. Vivero-Escoto, C. W. Wu, V. S. Y. Lin, Adv. Drug Delivery Rev. 2008, 60, 1278-1288.
25. I. F. Tannock, D. Rotin, Cancer Res. 1989, 49, 4373-4384.
26. N. Fehrenbacher, M. Jaattela, Cancer Res. 2005, 65, 2993-2995.
27. M. S. Lesniak, U. Upadhyay, R. Goodwin, B. Tyler, H. Brem, Anticancer Res. 2005, 25, 3825-3831.
28. L. Aubry, G. Klein, J. L. Martiel, M. Satre, J. Cell Sci. 1993, 105, 861-866.
29. J. V. Jokerst, M. Thangaraj, P. J. Kempen, R. Sinclair, S. S. Gambhir, ACS Nano 2012, 6, 5920-5930.
30. H. Yukawa, Y. Kagami, M. Watanabe, K. Oishi, Y. Miyamoto, Y. Okamoto, M. Tokeshi, N. Kaji, H. Noguchi, K. Ono, M. Sawada, Y. Baba, N. Hamajima, S. Hayashi, Biomaterials 2010, 31, 4094-4103.